KKR Stock Analysis: KKR & Co. | NYSE
Asset Management | NYSE, USA | Market Cap: 84.324m USD | 12M Return: -27% | US48251W1045 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 389M
EPS Trend: 93.1%
Qual. Beats: 2
Rev. Trend: 36.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
KKR & Co. Inc. is a U.S.-listed (NYSE) alternative asset manager that operates across private equity, real estate, credit, and infrastructure strategies, conducting both direct investments and fund-of-fund investments. The firm pursues a broad range of transaction types, including leveraged buyouts, management buyouts, growth equity, mezzanine, distressed, and middle-market deals, and invests across virtually all industries with particular emphasis on technology (software, cybersecurity, fintech, semiconductors, IoT), financial services, healthcare, consumer products, and energy and infrastructure (including upstream oil and gas, minerals and royalties, and renewables). In real estate, KKR targets property-level equity, debt, and special situations, while its asset services platform spans B2B, B2C, and B2G verticals such as logistics, hospitality, utilities, and environmental services. As a large-cap financial services firm in the GICS Asset Management & Custody Banks sub-industry, KKR has been publicly traded since its 2010 IPO and generates revenue primarily through management fees, performance/carried interest, and balance-sheet investments alongside its funds.
- Asset Management AUM growth drives fee-related earnings expansion
- Insurance segment scaling accelerates permanent capital and recurring revenue
- Private credit origination margins widen as bank lending tightens
- Real estate realizations pressured by higher rates and valuation marks
- Capital deployment in private equity supports future carried interest realization
| Net Income: 3.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.63 > 1.0 |
| NWC/Revenue: 46.03% < 20% (prev 583.9%; Δ -537.9% < -1%) |
| CFO/TA 0.01 > 3% & CFO 2.49b > Net Income 3.15b |
| Net Debt (44.7b) to EBITDA (8.24b): 5.43 < 3 |
| Current Ratio: 9.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (945.6m) vs 12m ago -0.90% < -2% |
| Gross Margin: 22.49% > 18% (prev 17.53%; Δ 4.96% > 0.5%) |
| Asset Turnover: 5.30% > 50% (prev 4.20%; Δ 1.10% > 0%) |
| Interest Coverage Ratio: 2.63 > 6 (EBIT TTM 8.15b / Interest Expense TTM 3.10b) |
| A: 0.02 (Total Current Assets 10.9b - Total Current Liabilities 1.19b) / Total Assets 414b |
| B: 0.04 (Retained Earnings 14.6b / Total Assets 414b) |
| C: 0.02 (EBIT TTM 8.15b / Avg Total Assets 398b) |
| D: 0.09 (Book Value of Equity 31.0b / Total Liabilities 334b) |
| Altman-Z'' = 0.50 = B |
| DSRI: 0.10 (Receivables 259.5m/106b, Revenue 21.1b/16.0b) |
| GMI: 0.78 (GM 17.53% / 22.49%) |
| AQI: 1.60 (AQ_t 0.97 / AQ_t-1 0.61) |
| SGI: 1.32 (Revenue 21.1b / 16.0b) |
| TATA: 0.00 (NI 3.15b - CFO 2.49b) / TA 414b) |
| Beneish M = -3.38 (Cap -4..+1) = AA |
As of October 05, 2026, the stock is trading at USD 90.29 with a total of 4,730,473 shares traded. Over the past week, the price has changed by -6.60%, over one month by -15.16%, over three months by -3.60% and over the past year by -27.03%.
Current recommended Stop Loss: 86.20 (which is 4.5% or 1.3 ATR below the current price).
KKR & Co. has received a consensus analysts rating of 4.52. Therefore, it is recommended to buy KKR.
- StrongBuy: 12
- Buy: 8
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 128.4 | 42.2% |
P/E Trailing = 29.7394
P/E Forward = 12.987
P/S = 3.2642
P/B = 3.0613
P/EG = 0.4147
Revenue TTM = 21.1b USD
EBIT TTM = 8.15b USD
EBITDA TTM = 8.24b USD
Long Term Debt = 54.0b USD (from longTermDebt, last quarter)
Short Term Debt = 223.6m USD (from shortTermDebt, last quarter)
Debt = 55.2b USD (corrected: LT Debt 54.0b + ST Debt 223.6m) + Leases 982.0m
Net Debt = 44.7b USD (calculated: Debt 55.2b - CCE 10.5b)
Enterprise Value = 129b USD (84.3b + Debt 55.2b - CCE 10.5b)
Interest Coverage Ratio = 2.63 (Ebit TTM 8.15b / Interest Expense TTM 3.10b)
EV/FCF = 55.13x (Enterprise Value 129b / FCF TTM 2.34b)
FCF Yield = 1.81% (FCF TTM 2.34b / Enterprise Value 129b)
FCF Margin = 11.11% (FCF TTM 2.34b / Revenue TTM 21.1b)
Net Margin = 14.97% (Net Income TTM 3.15b / Revenue TTM 21.1b)
Gross Margin = 22.49% ((Revenue TTM 21.1b - Cost of Revenue TTM 16.3b) / Revenue TTM)
Gross Margin QoQ = 18.89% (prev 27.70%)
Tobins Q-Ratio = 0.31 (Enterprise Value 129b / Total Assets 414b)
Interest Expense / Debt = 5.62% (Interest Expense 3.10b / Debt 55.2b)
Taxrate = 16.94% (1.12b / 6.64b)
NOPAT = 6.77b (EBIT 8.15b * (1 - 16.94%))
Current Ratio = 9.17 (Total Current Assets 10.9b / Total Current Liabilities 1.19b)
Debt / Equity = 1.78 (Debt 55.2b / totalStockholderEquity, last quarter 31.0b)
Debt / EBITDA = 5.43 (Net Debt 44.7b / EBITDA 8.24b)
Debt / FCF = 19.09 (Net Debt 44.7b / FCF TTM 2.34b)
Total Stockholder Equity = 30.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.79% (Net Income 3.15b / Total Assets 414b)
RoE = 10.32% (Net Income TTM 3.15b / Total Stockholder Equity 30.5b)
RoCE = 9.64% (EBIT 8.15b / Capital Employed (Equity 30.5b + L.T.Debt 54.0b))
RoIC = 1.64% (NOPAT 6.77b / Invested Capital 412b)
WACC = 8.68% (E(84.3b)/V(140b) * Re(11.31%) + D(55.2b)/V(140b) * Rd(5.62%) * (1-Tc(0.17)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 40.14 | Cagr: 0.98%
[DCF] Terminal Value 71.86% ; FCFF base≈3.23b ; Y1≈2.83b ; Y5≈2.29b
[DCF] Fair Price = N/A (negative equity: EV 34.8b - Net Debt 44.7b = -9.84b; debt exceeds intrinsic value)
EPS Correlation: 93.12 | EPS CAGR: 19.41% | SUE: 3.00 | # QB: 2
Revenue Correlation: 36.90 | Revenue CAGR: 8.34% | SUE: 0.65 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.61 | Chg30d=+0.37% | Revisions=+50% | Analysts=17
EPS current Year (2026-12-31): EPS=6.33 | Chg30d=+0.09% | Revisions=+62% | GrowthEPS=+29.9% | GrowthRev=+37.6%
EPS next Year (2027-12-31): EPS=7.40 | Chg30d=-0.08% | Revisions=+22% | GrowthEPS=+17.0% | GrowthRev=+17.6%
[Analyst] Revisions Ratio: +59% (up=12, down=2)